These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 26149262)

  • 1. Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.
    Sakakibara N; Baba M; Okamoto M; Toyama M; Demizu Y; Misawa T; Kurihara M; Irie K; Kato Y; Maruyama T
    Antivir Chem Chemother; 2015 Feb; 24(1):3-18. PubMed ID: 26149262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.
    Sakakibara N; Hamasaki T; Baba M; Demizu Y; Kurihara M; Irie K; Iwai M; Asada E; Kato Y; Maruyama T
    Bioorg Med Chem; 2013 Sep; 21(18):5900-6. PubMed ID: 23916148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives.
    Ordonez P; Hamasaki T; Isono Y; Sakakibara N; Ikejiri M; Maruyama T; Baba M
    Antimicrob Agents Chemother; 2012 May; 56(5):2581-9. PubMed ID: 22290950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and anti-HIV-1 activity of 1-substituted 3-(3,5-dimethylbenzyl)triazine derivatives.
    Sakakibara N; Balboni G; Congiu C; Onnis V; Demizu Y; Misawa T; Kurihara M; Kato Y; Maruyama T; Toyama M; Okamoto M; Baba M
    Antivir Chem Chemother; 2015 Apr; 24(2):62-71. PubMed ID: 26514833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives with potential anti-HIV activity.
    Isono Y; Sakakibara N; Ordonez P; Hamasaki T; Baba M; Ikejiri M; Maruyama T
    Antivir Chem Chemother; 2011 Oct; 22(2):57-65. PubMed ID: 21984685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anti-HIV-1 and anti-HCMV activity of 1-substituted 3-(3,5-dimethylbenzyl)uracil derivatives.
    Maruyama T; Kozai S; Demizu Y; Witvrouw M; Pannecouque C; Balzarini J; Snoecks R; Andrei G; De Clercq E
    Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):325-33. PubMed ID: 16508186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel uracil non-nucleoside derivatives as potential reverse transcriptase inhibitors of HIV-1.
    El-Brollosy NR; Al-Deeb OA; El-Emam AA; Pedersen EB; La Colla P; Collu G; Sanna G; Loddo R
    Arch Pharm (Weinheim); 2009 Nov; 342(11):663-70. PubMed ID: 19856332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N1,N3-disubstituted uracils as nonnucleoside inhibitors of HIV-1 reverse transcriptase.
    Novikov MS; Valuev-Elliston VT; Babkov DA; Paramonova MP; Ivanov AV; Gavryushov SA; Khandazhinskaya AL; Kochetkov SN; Pannecouque C; Andrei G; Snoeck R; Balzarini J; Seley-Radtke KL
    Bioorg Med Chem; 2013 Mar; 21(5):1150-8. PubMed ID: 23357038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of novel 6-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.
    Khalifa NM; Pedersen EB; Nielsen C; Al-Omar MA
    Bioorg Khim; 2014; 40(5):629-35. PubMed ID: 25895358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abasic analogues of TSAO-T as the first sugar derivatives that specifically inhibit HIV-1 reverse transcriptase.
    Velázquez S; Chamorro C; Pérez-Pérez MJ; Alvarez R; Jimeno ML; Martín-Domenech A; Pérez C; Gago F; De Clercq E; Balzarini J; San-Félix A; Camarasa MJ
    J Med Chem; 1998 Nov; 41(23):4636-47. PubMed ID: 9804703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines.
    Huang B; Liang X; Li C; Chen W; Liu T; Li X; Sun Y; Fu L; Liu H; De Clercq E; Pannecouque C; Zhan P; Liu X
    Eur J Med Chem; 2015 Mar; 93():330-7. PubMed ID: 25707013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
    Yang J; Chen W; Kang D; Lu X; Li X; Liu Z; Huang B; Daelemans D; Pannecouque C; De Clercq E; Zhan P; Liu X
    Eur J Med Chem; 2016 Feb; 109():294-304. PubMed ID: 26802545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors.
    Lu X; Chen Y; Guo Y; Liu Z; Shi Y; Xu Y; Wang X; Zhang Z; Liu J
    Bioorg Med Chem; 2007 Dec; 15(23):7399-407. PubMed ID: 17870545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Chen X; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Eur J Med Chem; 2012 May; 51():60-6. PubMed ID: 22405288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-[2-(2-Benzoyl- and 2-benzylphenoxy)ethyl]uracils as potent anti-HIV-1 agents.
    Novikov MS; Ivanova ON; Ivanov AV; Ozerov AA; Valuev-Elliston VT; Temburnikar K; Gurskaya GV; Kochetkov SN; Pannecouque C; Balzarini J; Seley-Radtke KL
    Bioorg Med Chem; 2011 Oct; 19(19):5794-802. PubMed ID: 21903401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
    Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
    Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and anti-HIV properties of novel 6-phenylselenenyl-5-propyluracils.
    Miazga A; Felczak K; Siwecka MA; Lipniacki A; Piasek A; Kulikowski T
    Acta Biochim Pol; 2007; 54(4):863-8. PubMed ID: 18066398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-HIV activity evaluation of 1-[(alkenyl or alkynyl or alkyloxy)methyl]-5-alkyl-6-(1-naphthoyl)-2,4-pyrimidinediones as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Ji L; Chen FE; Xie B; De Clercq E; Balzarini J; Pannecouque C
    Eur J Med Chem; 2007 Feb; 42(2):198-204. PubMed ID: 17095124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.
    Ranise A; Spallarossa A; Cesarini S; Bondavalli F; Schenone S; Bruno O; Menozzi G; Fossa P; Mosti L; La Colla M; Sanna G; Murreddu M; Collu G; Busonera B; Marongiu ME; Pani A; La Colla P; Loddo R
    J Med Chem; 2005 Jun; 48(11):3858-73. PubMed ID: 15916438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.